Wedgewood Pharmacy Compounds DMSO (Dimethylsulfoxide) 50% Aqueous Bladder Instillation Solution Duri

(Swedesboro NJ, July 22,2011) While DMSO (Dimethylsulfoxide) 50% Aqueous Bladder Instillation Solution is on extended backorder from the manufacturer, Wedgewood Pharmacy will compound this preparation in 50ml vials. Compounded DMSO from Wedgewood Pharmacy meets US Pharmacopoeia guidelines <795> and <797> for compounding non-sterile and sterile preparations.

DMSO has been examined for the treatment of numerous conditions and ailments, but the U.S. Food and Drug Administration (FDA) has approved its use only for the symptomatic relief of patients with interstitial cystitis.

During backorders or other shortages of commercially available medications, compounding pharmacies like Wedgewood Pharmacy are able to compound alternatives so that treatment regimens can continue uninterrupted.

Al Salciunas, Wedgewood Pharmacy’s human health product manager said, “A manufacturer backorder or commercial unavailability of a medication does not lessen a practitioner’s need for that medication as a treatment option. As a compounding pharmacy, we are able to provide DMSO so physicians can ensure the treatments they need are available for their patients.”

A compounding pharmacy creates customized medications for individual patients in response to a licensed practitioner’s prescription. Wedgewood Pharmacy is one of the largest compounding pharmacies in the United States, serving more than 25,000 prescribers of compounded medications. It is located in Swedesboro NJ and licensed throughout the United States. To learn more about compounding, visit wedgewoodrx.com/patients/facts-about-compounding.html.